PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
Dec 23, 2021 · Iona Everson from PMGroup spoke to John Forni, Country Medical Director at Sanofi UK & Ireland, about the escalating challenges of treating chronic obstructive pulmonary disease (COPD) in the UK and how the government, NHS and industry can work together to …
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
Susanne Bobadilla from VML Health, joined by a team of 15 medical, digital strategists and client engagement experts from across the company, looks at the top trends coming out of ESMO 2024 and what they mean for the future of cancer care
Regeneron shares positive phase 3 results for Libtayo in high-risk …
11 hours ago · Regeneron Pharmaceuticals has shared positive results from a late-stage trial of Libtayo (cemiplimab) in patients with high-risk cutaneous squamous cell carcinoma (CSCC) after surgery. The phase 3 C-POST trial has been comparing adjuvant treatment with the PD-1 inhibitor against placebo in patients ...
PME - Home
How AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020. As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate.
PME - Articles - Pharmaceutical Market Europe
Dec 15, 2024 · Discover the latest articles published by PME. Pharmaceutical industry news, articles, jobs, reports, advice and services!
Appointments - pme.pmlive.com
Edelman has appointed Anthony Chelvanathan as global creative partner. Chelvanathan, who will retain his chief creative officer role for Edelman Canada, has extensive industry experience. Prior to joining the firm, he worked his way up through a number of creative directing roles at Leo Burnett Toronto, culminating in his appointment as senior vice president.
About us - PMLiVE
DESIGN AND PRODUCTION. Hina Mistry – Designer Email: [email protected] Tel: +44 (0)1372 414 272. Anamaria Popescu – Front-End Developer Email: [email protected] Tel: +44 (0)1372 414 262
Research - PMLiVE
The research could pave the way for the development of new drugs that prevent drug resistance. Read More
Regeneron shares positive late-stage results for poze-cemdi in …
Dec 9, 2024 · Regeneron Pharmaceuticals has shared positive data from a phase 3 trial of pozelimab plus cemdisiran (poze-cemdi) in patients with the rare blood disorder paroxysmal nocturnal haemoglobinuria (PNH).
Comment - pme.pmlive.com
THE TEAM Editorial: Group Managing Editor Iona Everson Deputy Editor Emily Kimber Studio: Executive Director Karl Equi Sales: Business Director Tara Lovegrove EDITORIAL ADVISORY BOARD Philip Atkinson Founder of Hive-Logic, Lifescience Transformation Uday Bose Corporate vice president, head of global marketing oncology, Boehringer Ingelheim Dr Luc Hermans VP commercial planning and operations ...